Research article
Prescriptions for selective cyclooxygenase-2 inhibitors, non-selective non-steroidal anti-inflammatory drugs, and risk of breast cancer in a population-based case-control study
-
* Corresponding author: Deirdre P Cronin-Fenton dc@dce.au.dk
1 Department of Clinical Epidemiology, Aarhus University Hospital, Olof Palmes Alle 43-45, 8200 Aarhus N, Denmark
2 Department of Epidemiology, School of Public Health, Boston University, 715 Albany Street, TE3, Boston, MA 02118, USA
3 Institute of Cancer Epidemiology, The Danish Cancer Society, Strandboulevarden 49, 2100 Copenhagen Ø, Denmark
4 Departments of Community and Family Medicine and Medicine and the Norris Cotton Cancer Center, Dartmouth Hitchcock Medical Center, Lebanon, NH, USA
Breast Cancer Research 2010, 12:R15 doi:10.1186/bcr2482
Published: 1 March 2010Additional files
Additional file 1:
Tables S1-S3. Table S1: Duration and intensity of non-steroidal anti-inflammatory drug use (sCox-2 inhibitors and non-selective non-aspirin non-steroidal anti-inflammatory drugs) among women with at least 10 years of prescription history and odds ratio of breast cancer. Table S2: Duration and intensity of non-steroidal anti-inflammatory drug use (aspirin and non-selective non-aspirin non-steroidal anti-inflammatory drugs) among women with at least 10 years of prescription history and odds ratio of breast cancer. Table S3: Duration and intensity of aspirin use among women with at least 10 years of prescription history and odds ratio of breast cancer.
Format: DOCX Size: 33KB Download file
